The level playing field.
Al
A
Czap
D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D019587:Dietary Supplements / Q000009:adverse effects*; D005464:Fluorobenzenes / Q000009:adverse effects; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D018673:Nutrition Policy / Q000331:legislation & jurisprudence*; D011358:Product Surveillance, Postmarketing; D011743:Pyrimidines / Q000009:adverse effects; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000009:adverse effects; D014481:United States
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068258:Bevacizumab; D000068718:Rosuvastatin Calcium